How is insulin resistance diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Insulin Resistance

The most effective way to diagnose insulin resistance is through a combination of clinical evaluation for risk factors and specific laboratory tests including fasting plasma glucose, fasting insulin levels, oral glucose tolerance test (OGTT), and hemoglobin A1C. 1

Risk Assessment for Insulin Resistance

  • Overweight or obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans) is a significant risk factor for insulin resistance 1
  • Family history of type 2 diabetes increases the risk of insulin resistance 1, 2
  • Racial/ethnic predisposition (American Indian, African American, Hispanic, or Asian/Pacific Islander) should be considered when assessing risk 1, 2
  • Physical signs of insulin resistance include acanthosis nigricans, hypertension, dyslipidemia, or polycystic ovary syndrome 1, 2
  • Small-for-gestational-age birth weight is associated with increased risk of insulin resistance 2

Diagnostic Laboratory Tests

Primary Tests

  • Fasting plasma glucose (FPG): Values between 100-125 mg/dL indicate impaired fasting glucose, suggesting insulin resistance 1, 2
  • Fasting plasma insulin levels: Normal <15 mU/L, borderline high 15-20 mU/L, and high >20 mU/L 1
  • Oral glucose tolerance test (OGTT): 2-hour glucose values of 140-199 mg/dL indicate impaired glucose tolerance, suggesting insulin resistance 1, 2
  • Hemoglobin A1C: Values between 5.7-6.4% suggest prediabetes and potential insulin resistance 1, 2

Advanced Assessment

  • QUICKI method (Quantitative Insulin Sensitivity Check Index): Calculated as the inverse of the sum of the logarithms of fasting insulin and fasting glucose; may be more sensitive than fasting insulin alone 3
  • HOMA-IR (Homeostasis Model Assessment of Insulin Resistance): Correlates well with insulin resistance and doesn't significantly correlate with insulin secretion 4, 5
  • Insulin-to-glucose ratio at 30 minutes during OGTT can help assess insulin secretion capacity 4

Clinical Evaluation

  • Physical examination should focus on identifying:
    • Acanthosis nigricans (darkened, velvety skin patches, especially in neck folds and armpits) 1
    • Central obesity (waist circumference) 1
    • Signs of associated conditions like hypertension 1
  • Laboratory assessment should include:
    • Lipid profile (particularly triglycerides, which combined with fasting insulin provides better prediction of insulin resistance) 1, 5
    • Blood pressure measurement 1

Interpretation of Results

  • Impaired fasting glucose (100-125 mg/dL) indicates prediabetes and likely insulin resistance 1, 2
  • Impaired glucose tolerance (2-hour OGTT 140-199 mg/dL) suggests insulin resistance 1, 2
  • Elevated fasting insulin levels (>15 mU/L) directly indicate insulin resistance 1
  • A combination of elevated fasting insulin and elevated triglycerides provides better sensitivity for detecting insulin resistance than either measure alone 5

Common Pitfalls and Caveats

  • Testing should be performed in the fasting state to avoid postprandial variations 1
  • Medications that affect glucose metabolism should be noted when interpreting results 1
  • Stress hyperglycemia during acute illness can temporarily mimic insulin resistance and should not be used for diagnosis 1, 2
  • In diabetic patients, there are two subpopulations: those with elevated fasting insulin (insulin resistant) and those with normal or deficient insulin levels (insulin deficient) 3
  • Measuring C-peptide alongside insulin can help differentiate between endogenous insulin production and exogenous insulin administration 1

References

Guideline

Diagnosing Insulin Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.